Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448

April 17, 2014

French team presents novel V2 receptor antagonist peptides

April 10, 2014

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

April 3, 2014

AM-Pharma reports phase I data for recombinant human alkaline phosphatase

March 31, 2014

Enrollment begins in phase III study of ZS-9 in patients with hyperkalemia

March 28, 2014

Dimerix Bioscience raises funds to advance DMX-200

March 28, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Ipsen reports findings from phase IIa study of Dysport for neurogenic detrusor overactivity

March 19, 2014

Novel spirocyclic diamine derivatives with activity in animal models of CKD

March 17, 2014

World Kidney Day: Early diagnosis and more accessible solutions for chronic kidney disease

March 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...